Access Technology Solutions has received an undisclosed majority investment from Tritium Partners and StepStone Group. Ocean Avenue Capital Partners also participated in the funding. Pacific Crest Securities served as financial advisor to ATS. Based in Provo, Utah, ATS is a provider of cross-border ecommerce solutions.
GE Capital provided $69 million to help fund Vista Equity's acquisition of AGDATA. Based in Charlotte, NC, AGDATA is a a provider of data and analytics to agricultural and animal health manufacturers.
Ridgemont Equity Partners has agreed to buy a majority interest in Cross River Fiber, a regional provider of dark fiber and communications infrastructure-based services. The deal is expected to close in the fourth quarter. Financial details were not disclosed.
The Abraaj Group has sold its stake in lasacorp International, a Peru-based women's accessories retailer, to Peru's MCKPITAL, the family office of the Marsano family. The sale of lasacorp represents Abraaj's first exit in Peru. The firm invested in lasacorp in 2009 through its debut Latin American fund, ALAF I.
Thoma Bravo has agreed to make a significant equity investment in SailPoint, which provides identify and access management services. The deal is expected to close in the third quarter. Financial details were not disclosed.
Canadian private equity firm DRI Capital has purchased royalties relating to the worldwide sales of the drug Ampyra from Chicago-based healthcare institution Rush University Medical Center. The price for acquiring the royalties was approximately US$42 million. Ampyra is a therapy intended to help improve walking for people with multiple sclerosis. It was approved for use in the United States in January 2010 and has received conditional approval in Europe. The royalty rights were bought by Drug Royalty III, the third partnership of the Toronto-based DRI Capital, which closed last September at US$1.45 billion.
ValueAct Capital, a top shareholder in Valeant Pharmaceuticals International Inc, supports the company's independent business plan and does not believe the Canadian drugmaker has to buy Allergan Inc, the investor told Reuters. ValueAct likes a potential combination between Valeant and Allergan, but said a drawn-out bidding war for the Botox maker might be too distracting. Allergan is fighting a hostile US$52 billion bid from Valeant and William Ackman, head of hedge fund Pershing Square Capital Management.
Canadian Non-Operated Resources LP (CNOR), a newly founded Calgary oil and gas company, has secured an equity investment totaling $675 million. The deal includes a $300 million investment from U.S. resource-focused private equity firm Riverstone Holdings, with supplementary amounts coming from an unnamed Middle Eastern sovereign wealth fund, Canadian energy investment firm Grafton Asset Management Inc, and CNOR's management team. Led by Richard Grafton, founder and CEO of Grafton, who has launched multiple Calgary-based energy investments, the company will pursue partnerships with top-tier operators to develop oil and gas assets in the Western Canadian Sedimentary Basin.
Warburg Pincus is buying TriMark USA from the Audax Group, according to two sources and an FTC filing.
Graham Partners said Tuesday it closed the combined sale of Strata Products Worldwide and Strata Proximity Systems. Financial terms weren’t announced. Strata Products provides safety products and services to the mining industry. Strata Proximity makes proximity detection and collision avoidance systems for mining applications. Graham did not disclose the buyer.